7Baggers

Lantheus Holdings, Inc
(NASDAQ:LNTH) 

LNTH stock logo

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound ex...

Founded: 1956
Full Time Employees: 508
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
                                                
      revenues
    377,333,000 406,786,000 384,014,000 378,045,000 372,764,000 391,110,000 378,734,000 394,091,000 369,975,000 353,999,000 319,946,000 321,700,000 300,784,000 263,166,000 239,292,000 223,723,000 208,880,000 129,562,000 102,073,000 101,064,000 92,509,000 94,152,000 88,544,000 66,010,000 90,704,000 89,346,000 85,776,000 85,705,000 86,510,000 86,271,000 88,900,000 85,573,000 82,630,000 81,241,000 79,941,000 88,837,000 81,359,000 74,350,000 73,063,000 77,966,000 76,474,000 71,201,000 74,123,000 73,314,000 
      yoy
    1.23% 4.01% 1.39% -4.07% 0.75% 10.48% 18.37% 22.50% 23.00% 34.52% 33.71% 43.79% 44.00% 103.12% 134.43% 121.37% 125.79% 37.61% 15.28% 53.10% 1.99% 5.38% 3.23% -22.98% 4.85% 3.56% -3.51% 0.15% 4.70% 6.19% 11.21% -3.67% 1.56% 9.27% 9.41% 13.94% 6.39% 4.42% -1.43% 6.35%     
      qoq
    -7.24% 5.93% 1.58% 1.42% -4.69% 3.27% -3.90% 6.52% 4.51% 10.64% -0.55% 6.95% 14.29% 9.98% 6.96% 7.11% 61.22% 26.93% 1.00% 9.25% -1.75% 6.33% 34.14% -27.22% 1.52% 4.16% 0.08% -0.93% 0.28% -2.96% 3.89% 3.56% 1.71% 1.63% -10.01% 9.19% 9.43% 1.76% -6.29% 1.95% 7.41% -3.94% 1.10%  
      cost of goods sold
    146,411,000 165,911,000 161,648,000 137,034,000 135,064,000 142,565,000 136,608,000 138,317,000 128,129,000 124,130,000 119,995,000 119,053,000 223,708,000 95,995,000 91,859,000 85,694,000 79,810,000 71,654,000 59,404,000 54,976,000 51,479,000 55,501,000 52,284,000 40,162,000 52,702,000 44,781,000 44,187,000 41,132,000 42,426,000 42,426,000 44,015,000 41,727,000 40,321,000 43,342,000 41,414,000 42,890,000 41,597,000 39,703,000 39,382,000 42,215,000 42,773,000 37,820,000 40,418,000 40,647,000 
      gross profit
    230,922,000 240,875,000 222,366,000 241,011,000 237,700,000 248,545,000 242,126,000 255,774,000 241,846,000 229,869,000 199,951,000 202,647,000 77,076,000 167,171,000 147,433,000 138,029,000 129,070,000 57,908,000 42,669,000 46,088,000 41,030,000 38,651,000 36,260,000 25,848,000 38,002,000 44,565,000 41,589,000 44,573,000 44,084,000 43,845,000 44,885,000 43,846,000 42,309,000 37,899,000 38,527,000 45,947,000 39,762,000 34,647,000 33,681,000 35,751,000 33,701,000 33,381,000 33,705,000 32,667,000 
      yoy
    -2.85% -3.09% -8.16% -5.77% -1.71% 8.12% 21.09% 26.22% 213.78% 37.51% 35.62% 46.81% -40.28% 188.68% 245.53% 199.49% 214.57% 49.82% 17.68% 78.30% 7.97% -13.27% -12.81% -42.01% -13.80% 1.64% -7.34% 1.66% 4.20% 15.69% 16.50% -4.57% 6.41% 9.39% 14.39% 28.52% 17.98% 3.79% -0.07% 9.44%     
      qoq
    -4.13% 8.32% -7.74% 1.39% -4.36% 2.65% -5.34% 5.76% 5.21% 14.96% -1.33% 162.92% -53.89% 13.39% 6.81% 6.94% 122.89% 35.71% -7.42% 12.33% 6.16% 6.59% 40.28% -31.98% -14.73% 7.16% -6.69% 1.11% 0.55% -2.32% 2.37% 3.63% 11.64% -1.63% -16.15% 15.56% 14.76% 2.87% -5.79% 6.08% 0.96% -0.96% 3.18%  
      gross margin %
    61.20% 59.21% 57.91% 63.75% 63.77% 63.55% 63.93% 64.90% 65.37% 64.93% 62.50% 62.99% 25.63% 63.52% 61.61% 61.70% 61.79% 44.70% 41.80% 45.60% 44.35% 41.05% 40.95% 39.16% 41.90% 49.88% 48.49% 52.01% 50.96% 50.82% 50.49% 51.24% 51.20% 46.65% 48.19% 51.72% 48.87% 46.60% 46.10% 45.85% 44.07% 46.88% 45.47% 44.56% 
      operating expenses
                                                
      sales and marketing
    52,684,000 46,319,000 48,828,000 41,041,000 42,503,000 43,640,000 43,719,000 45,035,000 45,546,000 35,264,000 37,399,000 36,456,000 32,617,000 26,983,000 25,414,000 27,492,000 20,354,000 19,423,000 17,195,000 17,631,000 14,173,000 12,857,000 11,609,000 6,305,000 10,130,000 10,392,000 10,151,000 10,948,000 10,397,000 9,911,000 10,478,000 12,130,000 10,640,000 10,423,000 10,075,000 11,603,000 10,214,000 8,686,000 8,706,000      
      general and administrative
    57,533,000 69,892,000 81,898,000 66,515,000 56,816,000 57,869,000 40,516,000 47,409,000 47,895,000 40,295,000 35,741,000 26,151,000 23,271,000 39,639,000 23,759,000 32,598,000 37,588,000 62,530,000 28,550,000 43,177,000 16,138,000 13,684,000 18,217,000 20,670,000 16,699,000 17,301,000 18,061,000 13,293,000 12,589,000 12,440,000 13,609,000 11,575,000 12,543,000 14,293,000 12,076,000 11,203,000 12,270,000 9,990,000 10,091,000      
      research and development
    39,379,000 47,480,000 48,025,000 45,489,000 36,314,000 35,325,000 24,148,000 60,601,000 48,024,000 16,824,000 14,450,000 15,901,000 30,532,000 272,226,000 12,517,000 14,735,000 12,203,000 11,293,000 11,252,000 12,061,000 10,360,000 12,638,000 11,684,000 4,418,000 4,048,000 4,434,000 4,860,000 5,795,000 4,929,000 4,551,000 4,316,000 4,215,000 3,989,000 3,976,000 3,554,000 5,244,000 5,351,000 3,710,000 2,849,000      
      total operating expenses
    149,596,000 163,691,000 178,751,000 153,045,000 135,633,000 136,834,000 108,383,000 153,045,000 141,465,000 92,383,000 87,590,000 78,508,000 86,420,000 338,848,000 61,690,000 74,825,000 70,145,000 93,246,000 56,997,000 72,869,000 40,671,000 39,179,000 41,510,000 31,393,000 30,877,000 32,127,000 33,072,000 30,036,000 27,915,000 26,902,000 28,403,000 27,920,000 27,172,000 28,692,000 25,705,000 28,050,000 27,835,000 22,386,000 21,646,000 21,689,000 21,856,000 20,993,000 20,297,000 27,311,000 
      operating income
    81,326,000 77,184,000 43,615,000 87,966,000 102,067,000 113,872,000 133,743,000 102,729,000 106,635,000 137,486,000 112,361,000 124,139,000 -9,344,000 -171,677,000 85,743,000 63,204,000 58,925,000 -35,338,000 -14,328,000 -26,781,000 15,622,000 -528,000 -5,250,000 -5,545,000 7,125,000 12,438,000 8,517,000 14,537,000 16,169,000 16,943,000 16,482,000 15,926,000 15,137,000 9,207,000 12,822,000 17,897,000 11,927,000 12,141,000 12,595,000 14,179,000 17,673,000 12,388,000 13,408,000 5,356,000 
      yoy
    -20.32% -32.22% -67.39% -14.37% -4.28% -17.18% 19.03% -17.25% -1241.21% -180.08% 31.04% 96.41% -115.86% 385.81% -698.43% -336.00% 277.19% 6592.80% 172.91% 382.98% 119.26% -104.25% -161.64% -138.14% -55.93% -26.59% -48.33% -8.72% 6.82% 84.02% 28.54% -11.01% 26.91% -24.17% 1.80% 26.22% -32.51% -1.99% -6.06% 164.73%     
      qoq
    5.37% 76.97% -50.42% -13.82% -10.37% -14.86% 30.19% -3.66% -22.44% 22.36% -9.49% -1428.54% -94.56% -300.22% 35.66% 7.26% -266.75% 146.64% -46.50% -271.43% -3058.71% -89.94% -5.32% -177.82% -42.72% 46.04% -41.41% -10.09% -4.57% 2.80% 3.49% 5.21% 64.41% -28.19% -28.36% 50.05% -1.76% -3.60% -11.17% -19.77% 42.66% -7.61% 150.34%  
      operating margin %
    21.55% 18.97% 11.36% 23.27% 27.38% 29.12% 35.31% 26.07% 28.82% 38.84% 35.12% 38.59% -3.11% -65.24% 35.83% 28.25% 28.21% -27.27% -14.04% -26.50% 16.89% -0.56% -5.93% -8.40% 7.86% 13.92% 9.93% 16.96% 18.69% 19.64% 18.54% 18.61% 18.32% 11.33% 16.04% 20.15% 14.66% 16.33% 17.24% 18.19% 23.11% 17.40% 18.09% 7.31% 
      interest expense
    4,864,000 5,078,000 4,950,000 4,917,000 4,804,000 5,045,000 4,903,000 4,862,000 4,859,000 5,041,000 5,054,000 4,933,000 4,991,000 2,581,000 1,626,000 1,469,000 1,509,000 1,528,000 1,569,000 1,937,000 2,718,000 2,811,000 2,808,000 1,914,000 1,946,000 2,126,000 2,356,000 4,543,000 4,592,000 4,611,000 4,446,000 4,298,000 4,050,000 4,263,000 4,442,000 4,285,000 -5,420,000 -5,836,000 -6,786,000 -6,978,000 -7,018,000 -7,116,000 -7,100,000 -13,876,000 
      investment in equity securities - unrealized loss
    -14,905,000   -14,573,000 14,862,000   22,537,000                                     
      gain on sale of business, net of transaction costs
    -59,328,000                                            
      other income
    -5,710,000 -7,747,000 -2,556,000 -6,895,000 -14,128,000 -6,946,250 -9,953,000 -9,044,000 -8,788,000   -4,482,000 -3,231,000 76,500 1,101,000 -310,000 -485,000   -182,000 -549,000   -756,000 -350,000   -1,312,000 -1,187,000 -410,000 -799,000 -336,000 -920,000   -552,000 577,000 -80,000 -154,000 396,000 58,000 -323,000 -183,000 800,000 
      income before income taxes
    156,405,000 70,365,000 42,381,000 104,517,000 96,529,000 -783,000 176,118,000 84,374,000 171,268,000 138,403,000 159,956,000 123,688,000 -11,104,000 -176,243,000 83,016,000 62,045,000 57,901,000 -41,007,000 -19,837,000 -28,536,000 14,342,000 -2,843,000 -7,462,000 -6,703,000 5,529,000 2,396,000 5,357,000 8,110,000 12,764,000 12,742,000 12,835,000 11,964,000 12,007,000 11,264,000 9,288,000 14,164,000 4,923,000 5,744,000 4,240,000 7,597,000 10,713,000 4,973,000 6,125,000 -23,248,000 
      income tax expense
    37,988,000 16,277,000 14,610,000 25,762,000 23,584,000 11,007,000 45,025,000 22,301,000 40,202,000 35,023,000 27,999,000 29,557,000 -8,297,000 -57,058,000 21,784,000 18,987,000 14,939,000 -792,000 -6,422,000 -1,879,000 5,334,000 569,000 -1,076,000 309,000 2,192,000 -8,054,000 501,000 1,698,000 2,815,000 -551,000 3,566,000 2,219,000 3,796,000            
      net income
    118,417,000 54,088,000 27,771,000 78,755,000 72,945,000 -11,790,000 131,093,000 62,073,000 131,066,000 103,380,000 131,957,000 94,131,000 -2,807,000 -119,185,000 61,232,000 43,058,000 42,962,000 -40,215,000 -13,415,000 -26,657,000 9,008,000 -3,412,000 -6,386,000 -7,012,000 3,337,000 10,450,000 4,856,000 6,412,000 9,949,000 13,293,000 9,269,000 9,745,000 8,211,000 97,126,000 8,526,000 13,595,000 4,138,000 4,869,000 4,220,000 7,350,000 10,323,000 3,916,000 5,386,000 -24,423,000 
      yoy
    62.34% -558.76% -78.82% 26.87% -44.34% -111.40% -0.65% -34.06% -4769.26% -186.74% 115.50% 118.61% -106.53% 196.37% -556.44% -261.53% 376.93% 1078.63% 110.07% 280.16% 169.94% -132.65% -231.51% -209.36% -66.46% -21.39% -47.61% -34.20% 21.17% -86.31% 8.71% -28.32% 98.43% 1894.78% 102.04% 84.97% -59.91% 24.34% -21.65% -130.09%     
      qoq
    118.93% 94.76% -64.74% 7.96% -718.70% -108.99% 111.19% -52.64% 26.78% -21.66% 40.18% -3453.44% -97.64% -294.64% 42.21% 0.22% -206.83% 199.78% -49.68% -395.93% -364.01% -46.57% -8.93% -310.13% -68.07% 115.20% -24.27% -35.55% -25.16% 43.41% -4.88% 18.68% -91.55% 1039.17% -37.29% 228.54% -15.01% 15.38% -42.59% -28.80% 163.61% -27.29% -122.05%  
      net income margin %
    31.38% 13.30% 7.23% 20.83% 19.57% -3.01% 34.61% 15.75% 35.43% 29.20% 41.24% 29.26% -0.93% -45.29% 25.59% 19.25% 20.57% -31.04% -13.14% -26.38% 9.74% -3.62% -7.21% -10.62% 3.68% 11.70% 5.66% 7.48% 11.50% 15.41% 10.43% 11.39% 9.94% 119.55% 10.67% 15.30% 5.09% 6.55% 5.78% 9.43% 13.50% 5.50% 7.27% -33.31% 
      net income per common share:
                                                
      basic
    1,830 830 410 1,150 1,060 -170 1,890 890 1,910 1,520 1,930 1,380 -40 -1,740 890 630 630    130 -50 -100 -160 80 260 120 160 260 350 240 250 220 2,600 230 370 110 130 140      
      diluted
    1,800 810 410 1,120 1,020 -190 1,790 880 1,870 1,470 1,880 1,330 -40 -1,680 860 610 610    130 -50 -100 -160 80 260 120 160 250 340 240 250 210 2,500 220 350 110 110 130      
      weighted-average common shares outstanding:
                                                
      basic
    64,736,000 67,489,000 67,230,000 68,516,000 68,675,000 69,199,000 69,464,000 69,356,000 68,757,000 68,266,000 68,436,000 68,371,000 67,749,000 68,487,000 68,756,000 68,674,000 68,008,000 67,486,000 67,623,000 67,505,000 67,094,000 54,134,000 66,820,000 43,135,000 39,433,000 38,988,000 39,123,000 38,972,000 38,603,000 38,233,000 38,342,000 38,233,000 37,886,000 37,276,000 37,393,000 37,235,000 36,888,718,000 32,043,904,000 31,220,877,000 30,377,562,000     
      diluted
    65,772,000 68,443,000 67,663,000 70,312,000 71,461,000 71,651,000 73,065,000 70,601,000 70,095,000 70,239,000 70,046,000 71,014,000 67,749,000 70,671,000 71,075,000 70,796,000 70,051,000 67,486,000 67,623,000 67,505,000 67,714,000 54,134,000 66,820,000 43,135,000 40,102,000 40,113,000 40,286,000 40,239,000 39,787,000 39,501,000 39,402,000 39,398,000 39,493,000 38,892,000 39,121,000 38,900,000 38,601,356,000 32,655,958,000 32,402,297,000 30,542,728,000     
      gain on sale of assets
         2,161,000   6,254,000         3,815,750   15,263,000                   117,000 5,828,000    
      investment in equity securities - unrealized gain
     -217,750 -1,160,000   -18,873,000 -37,325,000  -60,704,000                                    
      other expense
             -15,090,500 -52,649,000               7,916,000 804,000       -6,601,000 -908,000          
      gain on extinguishment of debt
                     -222,250   -889,000                        
      other loss
                     4,141,000 3,940,000   -496,000 -596,000                      
      net loss per common share:
                                                
      basic
                     -115 -200 -390                         
      diluted
                     -115 -200 -390                         
      loss on extinguishment of debt
                               3,196,000      281,000   -2,161,000       -15,528,000 
      gain on sales of assets
                                         -120,000 560,000      
      debt retirement costs
                                         -481,000 -1,415,000      
      provision for income taxes
                                     529,000 762,000 569,000 785,000 875,000 20,000 247,000 390,000 1,057,000 739,000 1,175,000 
      net income per common share outstanding:
                                                
      basic
    1,830 830 410 1,150 1,060 -170 1,890 890 1,910 1,520 1,930 1,380 -40 -1,740 890 630 630    130 -50 -100 -160 80 260 120 160 260 350 240 250 220 2,600 230 370 110 130 140      
      diluted
    1,800 810 410 1,120 1,020 -190 1,790 880 1,870 1,470 1,880 1,330 -40 -1,680 860 610 610    130 -50 -100 -160 80 260 120 160 250 340 240 250 210 2,500 220 350 110 110 130      
      net income per weighted-average common share outstanding:
                                                
      basic
    1,830 830 410 1,150 1,060 -170 1,890 890 1,910 1,520 1,930 1,380 -40 -1,740 890 630 630    130 -50 -100 -160 80 260 120 160 260 350 240 250 220 2,600 230 370 110 130 140      
      diluted
    1,800 810 410 1,120 1,020 -190 1,790 880 1,870 1,470 1,880 1,330 -40 -1,680 860 610 610    130 -50 -100 -160 80 260 120 160 250 340 240 250 210 2,500 220 350 110 110 130      
      sales and marketing expenses
                                           9,843,000 9,307,000 7,806,000 8,633,000 9,229,000 
      general and administrative expenses
                                           9,238,000 9,513,000 10,121,000 9,206,000 15,444,000 
      research and development expenses
                                           2,608,000 3,036,000 3,066,000 2,458,000 2,638,000 
      net income per weighted-average common share outstanding:
                                                
      basic and diluted
                                           240 340 -207.5 180  
      net income per common share:
                                                
      basic and diluted
                                           240 340 -207.5 180  
      common shares:
                                                
      basic
                                            30,368,240,000 5,610,814,250 30,359,516,000  
      diluted
                                            30,372,691,000 5,610,814,250 30,761,771,000  
      net loss per common share:
                                                
      basic and diluted
                                               -1,290 
      common shares:
                                                
      basic and diluted
                                               18,898,003,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
                                                  
        assets
                                                  
        current assets:
                                                  
        cash and cash equivalents
      498,582,000 359,121,000 382,006,000 695,572,000 938,533,000 912,814,000 866,386,000 757,018,000 718,279,000 713,656,000 614,131,000 414,076,000 470,863,000 415,652,000 257,259,000 171,427,000 105,355,000 98,508,000 91,475,000 91,500,000 68,861,000 79,612,000 87,994,000 90,309,000 95,713,000 92,919,000 78,062,000 56,885,000 112,061,000 113,401,000 104,584,000 86,464,000 73,739,000 76,290,000 68,077,000 57,154,000 40,882,000 51,178,000 53,195,000 54,851,000 38,880,000 28,596,000 21,922,000 22,200,000 
        accounts receivable
      355,666,000 358,640,000 351,376,000 336,579,000 348,749,000 321,258,000 329,336,000 372,288,000 337,389,000 284,292,000 259,198,000 256,277,000 242,106,000 213,397,000 197,276,000 187,051,000 172,283,000 89,336,000 64,054,000 54,892,000 58,991,000 54,002,000 49,206,000 46,883,000 44,883,000 43,529,000 40,632,000 45,527,000 45,021,000 43,753,000 47,135,000 44,192,000 47,834,000 40,259,000 41,713,000 43,246,000 39,927,000 36,818,000 34,844,000 39,457,000 39,896,000 37,293,000 39,724,000 36,817,000 
        inventory
      61,339,000 64,674,000 62,040,000 62,157,000 69,126,000 68,025,000 70,835,000 70,516,000 69,758,000 64,029,000 56,462,000 51,801,000 42,156,000 35,475,000 34,793,000 33,958,000 34,249,000 35,129,000 33,949,000 31,719,000 30,357,000 35,744,000 37,623,000 35,334,000 30,814,000 29,180,000 30,596,000 32,414,000 32,044,000 33,019,000 34,572,000 31,474,000 32,086,000 26,080,000 23,032,000 21,151,000 19,790,000 17,640,000 16,057,000 14,433,000 15,541,000 15,622,000 16,579,000 15,396,000 
        income tax receivable
      1,487,000 15,387,000 31,877,000                                          
        other current assets
      25,214,000 21,400,000 21,169,000 34,093,000 67,372,000 24,536,000 21,998,000 24,165,000 16,215,000 16,683,000 11,485,000 22,906,000 10,949,000 13,092,000 12,570,000 11,986,000 12,860,000 12,818,000 12,043,000 8,102,000 10,145,000 9,625,000 9,709,000 8,630,000 8,967,000 7,283,000 5,096,000 5,035,000 6,372,000 5,242,000 4,669,000 4,925,000 5,598,000 5,221,000 3,789,000 4,072,000 6,084,000 5,183,000 6,369,000 4,282,000 5,721,000 3,946,000 5,210,000 4,577,000 
        assets held for sale
       80,742,000 76,623,000 73,415,000   7,159,000 7,159,000 7,159,000 7,159,000 7,159,000 7,159,000 7,200,000         5,242,000                    4,644,000   
        total current assets
      942,288,000 899,964,000 925,091,000 1,201,816,000 1,423,780,000 1,326,633,000 1,295,714,000 1,231,146,000 1,148,800,000 1,085,819,000 948,435,000 752,219,000 773,274,000 677,616,000 501,898,000 404,422,000 324,747,000 235,791,000 201,521,000 186,213,000 168,354,000 184,225,000 184,532,000 181,156,000 180,377,000 172,911,000 154,386,000 139,861,000 195,498,000 195,415,000 190,960,000 167,055,000 159,257,000 147,850,000 136,611,000 125,623,000 106,683,000 110,819,000 110,465,000 113,023,000 100,038,000 90,101,000 83,435,000 78,990,000 
        investment in equity securities
      58,312,000 42,213,000 46,474,000 45,068,000 30,375,000 39,489,000 158,791,000 116,423,000 138,960,000                                    
        long-term notes receivable
      92,103,000                                            
        property, plant and equipment
      157,563,000 163,686,000 164,072,000 157,726,000 180,783,000 176,798,000 169,512,000 158,158,000 150,090,000 146,697,000 140,293,000 129,981,000 127,478,000 122,166,000 120,826,000 119,004,000 116,959,000 116,772,000 116,441,000 118,493,000 118,381,000 120,171,000 122,381,000 122,903,000 108,613,000 116,497,000 113,531,000 113,117,000 112,211,000 107,888,000          84,422,000 85,324,000 86,517,000 92,393,000 92,867,000 
        intangibles
      706,058,000 722,779,000 739,264,000 359,946,000 153,745,000 161,761,000 173,606,000 172,239,000 142,054,000 151,985,000 163,294,000 221,004,000 219,863,000 315,285,000 323,591,000 331,898,000 340,204,000 348,510,000 356,883,000 365,259,000 371,331,000 376,012,000 384,747,000 389,512,000 6,930,000 7,336,000 7,786,000 8,239,000 8,686,000 9,133,000 9,727,000 10,409,000 11,106,000 11,798,000 12,645,000 13,456,000 14,288,000 15,118,000 16,406,000 17,949,000 19,235,000 20,496,000 22,489,000 24,099,000 
        goodwill
      239,399,000 239,517,000 240,328,000 176,869,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 61,189,000 58,632,000 57,765,000 57,765,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 15,714,000 
        deferred tax assets
      89,122,000 109,196,000 107,450,000 138,262,000 168,885,000 170,233,000 144,641,000 151,185,000 138,898,000 150,198,000 152,189,000 134,201,000 133,874,000 110,647,000 46,806,000 55,155,000 47,868,000 62,764,000 66,493,000 64,777,000 62,832,000 70,147,000 69,345,000 67,441,000 70,454,000 71,834,000 77,745,000 79,170,000 79,755,000 81,449,000 79,358,000 82,039,000 83,655,000 87,010,000           
        other long-term assets
      61,742,000 50,044,000 53,721,000 36,390,000 36,467,000 44,237,000 46,177,000 49,491,000 51,343,000 55,261,000 56,210,000 39,126,000 33,606,000 34,355,000 41,628,000 42,156,000 42,199,000 38,758,000 45,289,000 61,871,000 61,361,000 60,634,000 60,824,000 60,918,000 22,037,000 21,627,000 33,247,000 34,149,000 32,044,000 30,232,000 29,652,000 29,769,000 29,080,000 28,487,000 21,535,000 21,222,000 20,792,000 20,060,000 19,728,000 20,038,000 20,337,000 20,414,000 20,120,000 19,781,000 
        total assets
      2,346,587,000 2,227,399,000 2,276,400,000 2,116,077,000 2,055,224,000 1,980,340,000 2,049,630,000 1,939,831,000 1,831,334,000 1,651,149,000 1,521,610,000 1,337,720,000 1,349,284,000 1,321,258,000 1,095,938,000 1,013,824,000 933,166,000 863,784,000 847,816,000 857,802,000 843,448,000 869,821,000 879,594,000 879,695,000 404,125,000 405,919,000 402,409,000 390,250,000 443,908,000 439,831,000 424,818,000 401,803,000 392,589,000 383,858,000 281,021,000 267,878,000 249,563,000 255,898,000 254,969,000 259,267,000 249,263,000 242,379,000 236,132,000 233,550,000 
        liabilities and stockholders’ equity
                                                  
        current liabilities:
                                                  
        current portion of long-term debt and other borrowings
      803,000 738,000 871,000 796,000 747,000 974,000 564,713,000 868,000 734,000 823,000 703,000 384,000 422,000 354,000 15,372,000 14,065,000 12,878,000 11,642,000 10,356,000 10,372,000 10,251,000 20,701,000 18,138,000 17,143,000 10,143,000 10,143,000 10,166,000 10,136,000 2,854,000                
        accounts payable
      45,875,000 42,906,000 66,296,000 40,891,000 44,874,000 34,560,000 44,914,000 49,774,000 37,525,000 41,189,000 37,076,000 38,861,000 30,798,000 20,563,000 30,135,000 21,153,000 22,383,000 20,787,000 20,508,000 21,471,000 19,099,000 16,284,000 24,070,000 16,301,000 18,980,000 18,608,000 16,492,000 17,149,000 15,323,000 17,955,000 20,363,000 15,313,000 21,012,000 17,464,000 18,756,000 17,674,000 17,566,000 18,940,000 13,617,000 12,778,000 12,984,000 11,657,000 10,700,000 14,203,000 
        accrued expenses and other current liabilities
      286,488,000 267,307,000                                     21,850,000      
        liabilities held for sale
       22,468,000 28,566,000 29,845,000                  1,793,000                    1,715,000   
        total current liabilities
      333,166,000 333,419,000 346,838,000 280,132,000 248,002,000 240,526,000 784,079,000 263,285,000 237,198,000 187,350,000 176,602,000 154,043,000 276,388,000 247,701,000 235,984,000 219,016,000 177,657,000 90,497,000 76,903,000 73,826,000 64,590,000 80,504,000 82,000,000 76,336,000 61,959,000 66,111,000 59,586,000 53,357,000 42,768,000 52,755,000 54,577,000 43,249,000 45,396,000 46,750,000 46,087,000 43,064,000 39,130,000 43,839,000 39,117,000 34,092,000 31,479,000 35,718,000 34,318,000 37,545,000 
        asset retirement obligations
      139,000 138,000 137,000 136,000 18,740,000 23,344,000 23,237,000 23,130,000 23,023,000 22,916,000 22,823,000 22,729,000 22,636,000 22,543,000 23,358,000 22,196,000 21,514,000 20,833,000 15,185,000 14,797,000 14,408,000 14,020,000 13,962,000 13,602,000 13,243,000 12,883,000 12,560,000 12,237,000 11,895,000 11,572,000 11,282,000 10,992,000 10,702,000 10,412,000 10,151,000 9,891,000 9,630,000 9,370,000    8,145,000   
        long-term debt and other borrowings, net of current portion
      569,604,000 568,678,000 567,937,000 566,847,000                                         
        long-term deferred tax liabilities
      53,508,000 54,246,000 55,078,000                                          
        long-term contingent consideration liabilities, net of current portion
      72,647,000                                            
        other long-term liabilities
      105,235,000 107,866,000 116,180,000 102,179,000 58,190,000 63,180,000 61,993,000 63,543,000 63,107,000 63,321,000 62,850,000 49,068,000 46,208,000 46,155,000 46,489,000 49,616,000 58,776,000 124,894,000 89,643,000 91,790,000 64,857,000 63,393,000 65,384,000 64,164,000 29,037,000 28,397,000 42,724,000 43,703,000 42,739,000 40,793,000 39,321,000 38,478,000 37,855,000 38,012,000 37,176,000 36,174,000 35,628,000 34,745,000 33,716,000 34,055,000 34,237,000 33,947,000 33,518,000 32,799,000 
        total liabilities
      1,134,299,000 1,137,602,000 1,157,194,000 949,294,000 891,030,000 892,329,000 869,922,000 913,146,000 885,794,000 835,257,000 822,851,000 785,075,000 903,768,000 874,111,000 457,888,000 446,492,000 417,316,000 399,345,000 348,472,000 349,662,000 315,329,000 355,616,000 366,015,000 364,112,000 285,727,000 291,318,000 301,243,000 298,003,000 360,695,000 368,829,000 369,310,000 357,270,000 358,925,000 360,567,000 358,937,000 355,058,000 350,723,000 362,414,000 376,125,000 425,635,000 423,482,000 427,668,000 426,277,000 429,132,000 
        commitments and contingencies
                                                  
        stockholders' equity:
                                                  
        preferred stock
                                                  
        common stock
      723,000 718,000 718,000 717,000 716,000 709,000 709,000 708,000 706,000 699,000 698,000 698,000 696,000 689,000 688,000 687,000 686,000 677,000 677,000 676,000 674,000 669,000 668,000 668,000 398,000 393,000 392,000 390,000 388,000 385,000 385,000 383,000 380,000 378,000 375,000 373,000 371,000 367,000 357,000 303,000 303,000 303,000 303,000 303,000 
        additional paid-in capital
      892,949,000 888,320,000 871,193,000 844,903,000 821,346,000 817,972,000 797,430,000 775,545,000 756,443,000 757,727,000 743,973,000 729,733,000 717,163,000 715,875,000 708,341,000 699,526,000 691,516,000 685,472,000 680,819,000 676,059,000 669,623,000 665,530,000 661,955,000 657,669,000 253,530,000 251,641,000 248,694,000 244,600,000 242,068,000 239,865,000 237,587,000 235,882,000 234,765,000 232,960,000 228,934,000 228,083,000 227,680,000 226,462,000 216,814,000 176,545,000 175,960,000 175,553,000 175,075,000 174,581,000 
        treasury stock
      -477,438,000 -477,438,000 -376,456,000 -275,000,000 -175,000,000 -175,000,000 -75,000,000 -75,000,000 -75,000,000 -75,000,000 -75,000,000 -75,000,000 -75,000,000 -75,000,000                               
        retained earnings
      797,921,000 679,504,000 625,416,000 597,645,000 518,890,000 445,945,000 457,735,000 326,642,000 264,569,000 133,503,000                                   
        accumulated other comprehensive loss
      -1,867,000 -1,307,000 -1,665,000 -1,482,000 -1,758,000 -1,615,000 -1,166,000 -1,210,000 -1,178,000 -1,037,000 -1,035,000 -952,000 -1,378,000 -1,259,000    -485,000 -1,142,000 -1,000,000 -1,240,000 -2,048,000 -2,510,000 -2,606,000 -2,394,000 -960,000 -997,000 -964,000 -1,052,000 -1,108,000 -1,032,000 -1,030,000 -1,034,000 -1,034,000 -1,086,000 -971,000 -951,000 -947,000 -1,060,000 -1,729,000 -1,645,000 -1,985,000 -2,447,000 -2,004,000 
        total stockholders’ equity
      1,212,288,000 1,089,797,000 1,119,206,000 1,166,783,000 1,164,194,000 1,088,011,000 1,179,708,000 1,026,685,000 945,540,000 815,892,000 698,759,000 552,645,000 445,516,000 447,147,000 638,050,000 567,332,000 515,850,000 464,439,000 499,344,000 508,140,000 528,119,000 514,205,000 513,579,000 515,583,000 118,398,000 114,601,000 101,166,000 92,247,000 83,213,000 71,002,000 55,508,000 44,533,000 33,664,000 23,291,000           
        total liabilities and stockholders’ equity
      2,346,587,000 2,227,399,000 2,276,400,000 2,116,077,000 2,055,224,000 1,980,340,000 2,049,630,000 1,939,831,000 1,831,334,000 1,651,149,000 1,521,610,000 1,337,720,000 1,349,284,000 1,321,258,000 1,095,938,000 1,013,824,000 933,166,000 863,784,000 847,816,000 857,802,000 843,448,000 869,821,000 879,594,000 879,695,000 404,125,000 405,919,000 402,409,000 390,250,000 443,908,000 439,831,000 424,818,000 401,803,000 392,589,000 383,858,000           
        long-term contingent consideration liabilities
       73,255,000 71,024,000                                          
        accrued expenses and other liabilities
        251,105,000 208,600,000 202,381,000 204,992,000 174,452,000 212,643,000 198,939,000 145,338,000 138,823,000 114,798,000 145,468,000 127,084,000 190,477,000 183,798,000 142,396,000 58,068,000 46,039,000 41,983,000 35,240,000 41,726,000 39,792,000 42,892,000 32,836,000 37,360,000 32,928,000 26,072,000 24,591,000 32,050,000 31,464,000 25,186,000 21,634,000 26,536,000 24,581,000 22,640,000 18,814,000 21,249,000  17,664,000 14,845,000 18,696,000 19,968,000 19,692,000 
        current assets
                                                  
        current liabilities
                                                  
        long-term debt, net and other borrowings
          566,098,000 565,279,000 613,000 563,188,000 562,466,000 561,670,000 560,576,000 559,235,000 558,536,000 557,712,000 152,057,000 155,664,000 159,369,000 163,121,000 166,741,000 169,249,000 171,474,000 197,699,000 204,669,000 210,010,000 181,488,000 183,927,000 186,373,000 188,706,000 263,293,000                
        stockholders’ equity
                                                  
        short-term contingent liability
                  99,700,000 99,700,000                               
        accumulated deficit
                30,123,000 -101,834,000 -195,965,000 -193,158,000 -73,973,000 -135,205,000 -178,263,000 -221,225,000 -181,010,000 -167,595,000 -140,938,000 -149,946,000 -146,534,000 -140,148,000 -133,136,000 -136,473,000 -146,923,000 -151,779,000 -158,191,000 -168,140,000 -181,432,000 -190,702,000 -200,447,000 -209,013,000 -306,139,000 -314,665,000 -328,260,000 -332,398,000 -337,267,000 -341,487,000 -348,837,000 -359,160,000 -363,076,000 -368,462,000 
        accumulated other comprehensive income
                    2,994,000 2,324,000 1,911,000                            
        revolving line of credit
                                                  
        current portion of long-term debt
                                   2,750,000 2,750,000 2,750,000 2,750,000 2,750,000 2,750,000 2,750,000 2,750,000 3,650,000 3,650,000 3,650,000 3,650,000 3,650,000 3,650,000 3,650,000 
        long-term debt
                                   263,709,000 264,130,000 264,551,000 264,972,000 265,393,000 265,523,000 265,929,000 266,335,000 274,460,000 294,582,000 348,838,000 349,349,000 349,858,000 350,367,000 350,927,000 
        property, plant & equipment
                                    99,407,000 96,817,000 93,777,000 92,999,000 94,516,000 91,863,000 92,086,000 94,187,000 84,980,000      
        liabilities and stockholders’ deficit
                                                  
        stockholders’ deficit
                                                  
        total stockholders’ deficit
                                        -77,916,000 -87,180,000 -101,160,000 -106,516,000 -121,156,000 -166,368,000 -174,219,000 -185,289,000 -190,145,000 -195,582,000 
        total liabilities and stockholders’ deficit
                                        281,021,000 267,878,000 249,563,000 255,898,000 254,969,000 259,267,000 249,263,000 242,379,000 236,132,000 233,550,000 
        capitalized software development costs
                                            7,676,000 8,121,000 8,615,000 9,137,000 1,981,000 2,099,000 
        asset retirement obligation
                                            8,710,000 8,650,000 8,417,000  8,074,000 7,861,000 
        stockholders’ deficit:
                                                  
        line of credit
                                                  
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
                                                   
          cash flows from operating activities:
                                                   
          net income
        118,417,000 54,088,000 27,771,000 78,755,000 72,945,000 -11,790,000 131,093,000 62,073,000 131,066,000 103,380,000 131,957,000 94,131,000 -2,807,000 -119,185,000 61,232,000 43,058,000 42,962,000    9,008,000 -3,412,000 -6,386,000 -7,012,000 3,337,000 10,450,000 4,856,000 6,412,000 9,949,000 13,293,000 9,269,000 9,745,000 8,211,000 97,126,000 8,526,000 13,595,000 4,138,000 4,869,000 4,220,000 7,350,000 10,323,000   
          adjustments to reconcile net income to net cash flows from operating activities:
                                                   
          depreciation, amortization and accretion
        22,683,000 22,833,000 20,408,000 13,231,000 13,626,000 17,285,000 17,075,000 14,819,000 15,445,000 15,015,000 14,653,000 15,760,000 14,615,000 11,881,000 12,155,000 12,107,000 11,786,000 12,200,000 12,339,000 9,626,000 8,123,000 8,394,000 8,531,000 4,032,000 3,732,000 3,539,000 3,263,000 3,254,000 3,323,000 3,385,000 3,455,000 3,493,000 3,596,000 4,212,000 3,748,000 5,111,000 6,160,000    4,586,000   
          adjustment to the fair value of asset retirement obligation
         -4,727,000                                       
          amortization of debt-related costs
        1,115,000 1,114,000 1,113,000                                         
          change in fair value of contingent assets and liabilities
        -358,000                                           
          inventory adjustments
        1,537,000 -667,000 1,933,000 2,314,000 -1,378,000                                       
          stock-based compensation
        16,041,000 17,543,000 24,501,000 22,321,000 21,198,000 22,164,000 20,366,000 18,479,000 15,384,000 14,172,000 13,976,000 12,692,000 9,667,000 8,124,000 8,103,000 7,412,000 5,623,000 4,162,000 3,867,000 4,588,000 3,317,000 3,623,000 3,992,000 3,385,000 3,075,000 2,991,000 3,423,000 3,358,000 2,720,000 2,299,000 2,407,000 2,216,000 1,796,000 2,164,000 1,657,000 1,162,000 945,000   585,000 407,000 478,000 591,000 
          unrealized loss on investment in equity securities
        -14,905,000   -14,573,000 14,862,000                                       
          charges incurred pursuant to acquired in-process research and development
         5,799,000 5,413,000                                       
          deferred taxes
        19,327,000 -1,784,000 28,956,000 -6,928,000 1,351,000 -25,627,000 3,227,000 -18,889,000 11,260,000 2,017,000 -18,033,000 -3,753,000 -35,863,000 -62,477,000 7,863,000 -7,582,000 14,180,000 3,409,000 -1,657,000 -1,896,000 4,581,000 -553,000 -1,848,000 -400,000 1,467,000 5,935,000 1,403,000 646,000 1,741,000 -1,458,000 2,681,000 1,616,000 2,923,000           
          long-term income tax payable and other long-term liabilities
        84,000 3,000,000 -2,751,000 -642,000 639,000 2,617,000 1,031,000 1,149,000 439,000 -359,000 -4,130,000 1,263,000 123,000 -11,939,000 -1,692,000 375,000 779,000 -4,295,000 -4,764,000 419,000 728,000 714,000 705,000 704,000 705,000 -14,269,000 -923,000 1,018,000 1,018,000 822,000 880,000 663,000 854,000           
          gain on sale of business, net of transaction costs
        -59,328,000                                           
          other
        -2,317,000 -348,000 2,259,000 2,441,000 822,000 5,022,000 2,590,000 2,886,000 1,696,000 1,737,000 1,383,000 510,000 1,225,000 871,000 1,016,000 1,343,000 829,000 788,000 627,000 442,000 655,000 706,000 411,000 -44,000 452,000 193,000 239,000 -4,000 -6,000 398,000 655,000 392,000 -46,000 -355,000 623,000 138,000 643,000 684,000 327,000 -395,000 513,000 -704,000 1,128,000 
          changes in operating assets and liabilities, excluding impact of acquisitions:
                                                   
          accounts receivable
        -2,232,000 -2,067,000 12,830,000 -2,288,000 -26,363,000 7,202,000 43,141,000 -32,588,000 -55,440,000 -25,593,000 -3,966,000 -14,397,000 -24,681,000 -16,429,000 -11,037,000 -15,839,000 -85,155,000 -25,381,000 -9,272,000 3,897,000 -2,346,000 -6,759,000 -2,790,000 3,837,000 -1,750,000 -2,922,000 4,833,000 -715,000 -1,040,000 3,220,000 -2,982,000 3,593,000 -7,816,000 1,202,000 1,759,000 -3,233,000 -3,135,000 -2,130,000 3,080,000 625,000 -2,634,000 -804,000 -3,468,000 
          inventory
        2,113,000 -3,041,000 -915,000 -5,688,000 278,000 4,431,000 874,000 519,000 -8,494,000 -10,225,000 -6,740,000 -12,131,000 -7,124,000 -2,842,000 -2,653,000 -379,000 -1,634,000 -2,924,000 -2,513,000 -2,001,000 3,889,000 1,134,000 -2,816,000 -4,679,000 -2,098,000 1,266,000 1,093,000 -830,000 465,000 1,142,000 -3,118,000 -135,000 -6,579,000 -3,259,000 -2,129,000 -1,805,000 -2,427,000 -1,968,000 -2,183,000 829,000 -304,000 -168,000 -1,967,000 
          other current and noncurrent assets
        -244,000 938,000 -4,428,000                                         
          accounts payable
        190,000 -31,965,000 20,108,000 4,383,000 4,982,000 -9,955,000 -5,722,000 10,335,000 -3,462,000 5,039,000 -2,036,000 7,439,000 6,747,000 -8,108,000 9,270,000 -2,367,000 1,506,000 649,000 -1,112,000 1,778,000 4,110,000 -7,986,000 7,214,000 -2,539,000 -913,000 1,779,000 -1,427,000 1,423,000 1,458,000 -5,086,000 5,100,000 -5,060,000 2,160,000 874,000 -1,037,000 -433,000 1,200,000 3,016,000 1,210,000 -596,000 2,070,000 1,085,000 -2,873,000 
          accrued expenses and other current and noncurrent liabilities
        23,004,000  -26,313,000 -5,947,000 3,328,000                                       
          net cash from operating activities
        125,127,000 90,178,000 105,294,000 87,106,000 107,563,000 157,730,000 175,062,000 84,720,000 127,238,000 112,287,000 116,739,000 -32,266,000 108,500,000 105,352,000 93,568,000 72,597,000 10,264,000 13,889,000 4,340,000 25,869,000 9,818,000 569,000 8,575,000 -2,156,000 9,408,000 22,421,000 26,442,000 21,053,000 10,468,000 17,306,000 24,277,000 20,276,000 -666,000 13,086,000 15,600,000 20,567,000 5,524,000       
          cash flows from investing activities:
                                                   
          capital expenditures
        -3,226,000 -8,788,000 -10,622,000 -7,961,000 -8,718,000 -16,369,000 -15,808,000 -11,175,000 -8,273,000 -12,069,000 -14,621,000 -10,697,000 -9,168,000 -4,724,000 -6,090,000 -4,343,000 -3,190,000 -4,544,000 -2,420,000 -2,656,000 -2,520,000 -3,785,000 -3,736,000 -2,255,000 -2,698,000 -4,741,000 -3,336,000 -3,434,000 -10,550,000 -7,366,000 -5,005,000 -5,626,000 -2,135,000 -5,954,000 -3,288,000 -3,402,000 -4,899,000       
          free cash flows
        121,901,000 81,390,000 94,672,000 79,145,000 98,845,000 141,361,000 159,254,000 73,545,000 118,965,000 100,218,000 102,118,000 -42,963,000 99,332,000 100,628,000 87,478,000 68,254,000 7,074,000 9,345,000 1,920,000 23,213,000 7,298,000 -3,216,000 4,839,000 -4,411,000 6,710,000 17,680,000 23,106,000 17,619,000 -82,000 9,940,000 19,272,000 14,650,000 -2,801,000 7,132,000 12,312,000 17,165,000 625,000       
          proceeds from sale of business, net of transaction costs
        24,212,000                                           
          proceeds from sale of assets
        5,000,000     9,767,000 8,000,000    1,800,000 15,823,000         1,000,000   899,000 335,000   9,000,000   
          deposit for acquisition of a business
            -50,000,000                                       
          purchases of investment in equity securities
         -5,000,000 -5,000,000 -4,990,000 -78,256,000                                   
          net cash from investing activities
        25,986,000 -11,510,000 -319,468,000 -232,472,000 -63,718,000 -6,602,000 -67,798,000 -45,086,000 -106,529,000 -12,069,000 83,218,000 -20,697,000 -44,513,000 -264,724,000 -6,090,000 -4,343,000 -1,390,000 -4,544,000 -2,420,000   -3,785,000 -3,736,000 5,307,000 -2,698,000 -4,741,000 -3,336,000 -3,434,000 -10,550,000 -7,366,000 -5,005,000 -5,626,000 -1,135,000 -5,954,000 -3,288,000 -2,503,000 -4,564,000       
          cash flows from financing activities:
                                                   
          payments of long-term debt and other borrowings
        -216,000 -353,000 -292,000                                         
          proceeds from stock option exercises
        1,697,000 681,000 142,000 2,445,000 3,886,000 -494,000 1,289,000 1,549,000 934,000 354,000 273,000 1,347,000 1,842,000 -1,000 758,000 1,423,000 5,357,000 679,000 530,000 2,043,000 2,043,000 27,000   729,000 120,000 324,000 12,000 626,000 514,000 2,037,000 132,000 446,000 632,000 170,000      
          proceeds from employee stock purchase plan
        2,591,000 1,000 1,743,000                                         
          payments for minimum statutory tax withholding related to net share settlement of equity awards
        -15,695,000 -1,098,000 -759,000 -795,000 -23,686,000 -892,000 -1,299,000 -1,006,000 -19,418,000 -773,000 -1,000,000 -1,467,000 -11,154,000 -588,000 -843,000 -824,000 -5,504,000 -187,000 -67,000 -193,000 -1,599,000 -47,000 -50,000 -485,000 -1,547,000 -44,000 -346,000 -944,000 -1,120,000 -218,000 -736,000 -1,723,000 -709,000 -172,000 -1,124,000 -1,202,000 -355,000       
          proceeds from issuance of common stock
            1,983,000 1,627,000 1,823,000 993,000 940,000 798,000 577,000 -1,000 431,000 337,000 317,000 366,000 291,000 282,000 222,000 206,000          
          net cash from financing activities
        -11,623,000 -100,786,000 -99,166,000 -98,413,000 -18,219,000 -103,659,000 1,869,000 99,000 -16,845,000 -450,000 108,000 -4,051,000 -8,669,000 317,840,000 -1,959,000 -2,011,000 -2,179,000 -2,100,000 -1,726,000 -715,000 -34,791,000 -4,373,000 -7,270,000 -6,486,000 -3,732,000 -2,823,000 -1,900,000 -72,927,000 -1,231,000 -934,000 -1,217,000 -1,813,000 -704,000 1,150,000 -1,519,000 -1,827,000 -11,254,000       
          effect of exchange rate changes on cash, cash equivalents and restricted cash
        -22,000 -760,000 -218,000                                         
          net increase in cash, cash equivalents and restricted cash
        139,468,000 -22,878,000 -313,558,000 -242,952,000 25,728,000  109,380,000 38,750,000 4,634,000  200,065,000 -56,777,000 55,220,000  85,272,000 66,073,000 6,846,000  -25,000 22,639,000 -11,691,000                       
          cash, cash equivalents and restricted cash, beginning of period
        360,826,000 914,486,000  715,285,000  417,241,000  100,651,000  82,694,000                      
          cash, cash equivalents and restricted cash, end of period
        500,294,000 -22,878,000 -313,558,000 -242,952,000 940,214,000  109,380,000 38,750,000 719,919,000  200,065,000 -56,777,000 472,461,000  85,272,000 66,073,000 107,497,000  -25,000 22,639,000 71,003,000  -2,315,000                     
          impairment of long-lived assets
                 5,998,000 132,052,000     189,000    2,660,000 7,275,000                   
          change in fair value of contingent liabilities
                                                   
          gain on disposal of assets
             -2,161,000 -6,254,000                                   
          gain on sale of relistor licensed intangible asset
                                                   
          long-term indemnification receivable
                 4,256,000 -231,000 -96,000                               
          accrued expenses and other current and long-term liabilities
                                                   
          acquisition of in-process research and development
                                                 
          acquisition of assets
             -47,000,000   -10,000,000 -35,345,000                               
          acquisition of evergreen, net of cash acquired
         165,000                                         
          acquisition of life molecular, net of cash acquired
         2,278,000                                          
          acquisition of exclusive license option
             -28,000,000                                   
          deferred financing costs
                             -1,000 2,000   -224,000       -357,000 -1,219,000   -7,000 -982,000 
          contingent value rights settlement
                                                 
          repurchase of common stock
         -100,017,000 -100,000,000                                         
          unrealized gain on investment in equity securities
              -37,325,000 22,537,000 -60,704,000                                   
          amortization of debt related costs
            1,115,000 1,079,000 1,072,000 1,072,000 1,073,000 1,073,000 1,072,000 1,073,000 1,082,000 512,000 246,000 245,000 246,000 246,000 245,000 246,000 -61,000 -80,000 -139,000 169,000 169,000 169,000 170,000 319,000 320,000 320,000 320,000 319,000 320,000 330,000 335,000         
          changes in assets and liabilities which provided (used) cash:
                                                   
          other current assets
            -528,000 3,105,000 -1,831,000 -857,000 4,023,000 -4,914,000 11,756,000 -11,739,000 2,479,000 -2,754,000 -430,000 848,000 -104,000 -2,071,000 -173,000 2,707,000 -536,000 378,000 -179,000 593,000 1,149,000 -2,215,000 -78,000 1,034,000 -1,152,000 -612,000 532,000 422,000 -1,003,000 -442,000 303,000 1,001,000 -1,250,000 877,000 -1,425,000 1,435,000 -1,042,000 943,000 -707,000 
          payments on long-term debt and other borrowings
            -402,000 58,000 252,000 -444,000 -184,000 -32,000 -157,000 -231,000 -297,000 -167,494,000 -2,672,000 -2,610,000 -2,609,000 -2,591,000 -2,620,000 -2,565,000 -35,572,000 -4,325,000 -4,134,000 -4,481,000 -2,551,000 -2,555,000 -2,574,000 -269,530,000 -717,000               
          effect of foreign exchange rates on cash, cash equivalents and restricted cash
            102,000  247,000 -983,000 770,000  237,000 -98,000  -247,000 -170,000 151,000  -219,000 141,000 -21,000  116,000                     
          operating activities
                                                   
          asset retirement obligation acceleration
                     -949,000 729,000                             
          gain on interest rate swap termination
                                                   
          changes in fair value of contingent assets and liabilities
             -1,294,000 -1,505,000   200,000 -500,000 -7,575,000 -1,400,000 9,300,000 -1,500,000 8,500,000 18,400,000 43,900,000 2,600,000 25,600,000 300,000 -2,800,000                      
          charges incurred in connection with acquired ipr&d
             38,000,000 28,000,000                                   
          loss on extinguishment of debt
                                         2,161,000     
          provision for excess and obsolete inventory
               -832,000 2,757,000 2,663,000 2,072,000 2,499,000 680,000 2,165,000 1,795,000 666,000 2,519,000 1,740,000 278,000 644,000 1,395,000 495,000   449,000 152,000   511,000 405,000 511,000 739,000 1,220,000 213,000 272,000 445,000 285,000 360,000 164,000 321,000 497,000 286,000 606,000 
          gain on sale of relistor licensed intangible asset associated with net sales royalties
                                                   
          other long-term assets
                     -533,000                           
          accrued expenses and other liabilities
             28,238,000 1,810,000 -33,730,000 50,449,000 8,082,000 22,808,000 -123,805,000 11,801,000 33,201,000 7,011,000 24,400,000 -1,037,000 12,204,000 3,927,000 6,634,000 -6,620,000 2,574,000 1,287,000 -733,000 -7,289,000 3,837,000 8,056,000 2,031,000 -7,847,000 -220,000 5,137,000 2,989,000 -5,656,000 2,288,000 1,543,000 3,890,000 -3,196,000 -1,155,000 4,479,000 2,591,000 -4,573,000 11,000 2,718,000 
          investing activities
                                                   
          financing activities
                                                   
          debt issuance costs
                                                   
          proceeds from issuance of long-term debt
                                       274,313,000     
          proceeds from interest rate swap termination
                                                   
          effect of foreign exchange rates on cash and cash equivalents
                                -184,000 -29,000 132,000 -27,000 -189,000 65,000 -112,000 -46,000 -69,000 130,000 35,000 -2,000 -181,000      
          net increase in cash and cash equivalents and restricted cash
                                                   
          cash and cash equivalents and restricted cash, beginning of year
                                                   
          cash and cash equivalents and restricted cash, end of year
                                                   
          (decreases) increases in cash from operating assets and liabilities:
                                                   
          loss on disposal of assets
                                                   
          increases (decreases) in cash from operating assets and liabilities:
                                                   
          lending on bridge loan
                                                 
          cash acquired in acquisition of business
                                                 
          equity issuance costs
                             -3,432,000                     
          gain on extinguishment of debt
                          -889,000                       
          gain on sale of assets
                          -15,263,000                   -117,000 -5,828,000   
          long-term income tax receivable
                      1,461,000 -397,000 -396,000  3,823,000 -158,000 -573,000 -554,000 -555,000 -555,000 -554,000 11,477,000 762,000 -802,000 -802,000 -635,000 -692,000 -687,000 -841,000           
          aro acceleration
                        293,000                           
          net loss
                          -13,415,000                       3,916,000 5,386,000 
          adjustments to reconcile net loss to net cash flows from operating activities:
                                                   
          net cash from from investing activities
                            13,303,000                       
          provision for bad debt
                                202,000 39,000   -190,000 33,000 122,000 -29,000 195,000           
          net decrease in cash, cash equivalents and restricted cash
                              -2,315,000                     
          benefit from bad debt
                                                   
          benefit from excess and obsolete inventory
                                                   
          net increase in cash and cash equivalents
                                2,794,000 14,857,000 21,177,000   8,817,000 18,120,000   8,213,000 10,923,000 16,272,000 -10,296,000       
          cash and cash equivalents, beginning of period
                                92,919,000  113,401,000  76,290,000  51,178,000  28,596,000  
          cash and cash equivalents, end of period
                                95,713,000  21,177,000 -55,176,000 112,061,000  18,120,000 12,725,000 73,739,000  10,923,000 16,272,000 40,882,000  -1,656,000 15,971,000 38,880,000  -278,000 
          loss on impairment of land
                                                   
          payments for public offering costs
                                                   
          cash and cash equivalents, beginning of year
                                                   
          cash and cash equivalents, end of year
                                                   
          net decrease in cash and cash equivalents
                                    -1,340,000    -2,551,000           
          gain on sales of assets
                                             120,000      
          loss on extinguishment of debt and debt retirement costs
                                         281,000          
          payments on long-term debt
                                     -716,000 -715,000 -716,000 -715,000 -715,000 -714,000 -714,000 -284,551,000   -928,000 -933,000 -931,000  
          write-off of deferred offering and financing costs
                                                   
          income taxes
                                                -235,000   
          payments on senior notes
                                                  
          payment for call premium on senior notes
                                                 
          net movement in line of credit
                                                   
          proceeds from sales of assets
                                                   
          redemption of certificate of deposit—restricted
                                                   
          debt retirement costs
                                             481,000      
          supplemental disclosure of cash flow information
                                                   
          cash paid during the period for:
                                                   
          interest
                                                   
          income taxes, net of refunds of 82, 363 and 317, respectively
                                                   
          schedule of non-cash investing and financing activities
                                                   
          additions of property, plant & equipment included in liabilities
                                                   
          receivable in connection with sale of australian subsidiary
                                                   
          adjustments to reconcile net income to cash flows from operating activities:
                                                   
          depreciation and amortization
                                              3,842,000    4,075,000 
          stock-based compensation expense
                                                   
          changes in operating assets and liabilities:
                                                   
          cash from operating activities
                                              15,446,000 17,635,000 3,780,000 12,626,000 5,417,000 
          redemption of certificate of deposit – restricted
                                                   
          cash from investing activities
                                              -1,047,000 -736,000 7,422,000 -4,732,000 -2,307,000 
          proceeds from issuance of common stock in public offering
                                                   
          payments for offering costs
                                                 
          principal payments on long-term debt
                                                   
          principal payments on senior notes
                                                   
          repayments of amounts borrowed under revolving line of credit
                                                   
          payments of minimum statutory tax withholdings on net share settlements of equity awards
                                                   
          cash from financing activities
                                              -16,086,000 -928,000 -944,000 -1,042,000 -3,014,000 
          increase in cash and cash equivalents
                                              -1,656,000 15,971,000 10,284,000 6,674,000 -278,000 
          cash flows from operating activities
                                                   
          adjustments to reconcile net loss to cash flow from operating activities
                                                   
          increase in cash from operating assets and liabilities
                                                   
          cash flows from investing activities
                                                   
          redemption of certificate of deposit - restricted
                                               74,000   
          cash flows from financing activities
                                                   
          proceeds from issuance of common stock in initial public offering
                                                 
          payments for initial public offering costs
                                                   
          payments on line of credit
                                                 
          payments on note payable
                                                   
          effect of foreign exchange rate on cash
                                               26,000 -178,000 -374,000 
          interest paid
                                               6,368,000 6,422,000 6,513,000 6,534,000 
          income taxes paid
                                                 93,000 8,000 
          adjustments to reconcile net income to cash flow from operating activities
                                                   
          income taxes paid/(refunded)
                                                199,000   
          cash flow from operating activities
                                                   
          impairment of land
                                                   
          impairment of intangible assets
                                                   
          proceeds from sale of property, plant and equipment
                                                   
          proceeds from line of credit
                                                   
          proceeds from issuance of common stock, other
                                                   
          payments for common stock repurchase
                                                   
          payments for tax withholding related to net share settlement of equity awards
                                                   
          payments of dividend
                                                   
          noncash investing and financing activities
                                                   
          property, plant and equipment included in accounts payable and accrued expenses and other liabilities
                                                 185,000 -636,000 
          deferred offering cost included in accounts payable and accrued expenses and other liabilities
                                                   
          deferred income taxes
                                                  -72,000 
          write-off of deferred financing costs
                                                   
          initial public offering costs
                                                  -1,003,000 
          payment for tax withholding related to net share settlement of equity awards
                                                   
          initial public offering costs included in accrued expenses and other liabilities
                                                   
          payments of senior notes
                                                   
          initial public offering costs included in accounts payable and accrued expenses and other liabilities
                                                   
          deferred financing costs included in accrued expenses and other liabilities